×
Back to Agenda
[Session 2] Safety Pharmacology Electrophysiology - Insights from the CiPA, JiCSA and iSmart Initiatives
Session Chair(s)
Kentaro Ando, PHD
Department of Pharmacology, Toho University Faculty of Medicine, Japan
Yasunari Kanda, PHD
Head of Division of Pharmacology, National Institute of Health Sciences, Japan
Speaker(s)
David Strauss, MD, PHD
Director, Division of Applied Regulatory Science, OCP, OTS, CDER, FDA, United States
US FDA CiPA Paradigm Overview
Kohei Sawada
Head of Global Cardiovascular Assessment, Eisai Co., Ltd., Japan
JiCSA Overview/Update
Keiichi Asakura, PHD
Senior Scientist, Pharmacokinetics and Safety Assessment Department, Nippon Shinyaku Co., Ltd., Japan
iSmart Update
Junko Kurokawa, PHD
Associate Professor, Medical Research Institute, Advanced Molecular Medicine, , Tokyo Medical and Dental University, Japan
Electrophysiological Properties of Human iPS-Derived Cardiomyocytes
Have an account?